# Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO)

> **NCT00115375** · PHASE2 · COMPLETED · sponsor: **Sanofi** · enrollment: 92 (actual)

## Conditions studied

- Congenital Heart Defects
- Blood Platelet Disorders

## Interventions

- **DRUG:** Clopidogrel (SR25990)

## Key facts

- **NCT ID:** NCT00115375
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** —
- **Final completion:** 2006-04
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2009-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00115375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00115375, "Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO)". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00115375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*